Most edited pathways

Showing below up to 500 results starting with #1.

View (previous 500) (next 500) (20 | 50 | 100 | 250 | 500)

1. Homo sapiens:Integrated breast cancer pathway ‎(450 revisions)
2. Homo sapiens:Aryl hydrocarbon receptor pathway ‎(267 revisions)
3. Homo sapiens:Selenium micronutrient network ‎(214 revisions)
4. Homo sapiens:Sudden infant death syndrome (SIDS) susceptibility pathways ‎(186 revisions)
5. Homo sapiens:Folate metabolism ‎(179 revisions)
6. Homo sapiens:ATM signaling pathway ‎(155 revisions)
7. Homo sapiens:ADHD and autism (ASD) pathways ‎(151 revisions)
8. Homo sapiens:Retinoblastoma gene in cancer ‎(147 revisions)
9. Homo sapiens:Sterol regulatory element-binding proteins (SREBP) signaling ‎(146 revisions)
10. Homo sapiens:Zinc homeostasis ‎(137 revisions)
11. Caenorhabditis elegans:Mitochondrial unfolded-protein response ‎(133 revisions)
12. Clostridium thermocellum:Combined Pathways (Network) for Cellulose Digestion ‎(131 revisions)
13. Homo sapiens:ErbB signaling pathway ‎(120 revisions)
14. Homo sapiens:SARS-CoV-2 and COVID-19 pathway ‎(119 revisions)
15. Homo sapiens:Tissue fate map ‎(118 revisions)
16. Homo sapiens:Vitamin D metabolism ‎(116 revisions)
17. Homo sapiens:Senescence and autophagy in cancer ‎(109 revisions)
18. Homo sapiens:Vitamin B12 metabolism ‎(108 revisions)
19. Homo sapiens:DNA damage response ‎(105 revisions)
20. Homo sapiens:TCA cycle (aka Krebs or citric acid cycle) ‎(105 revisions)
21. Homo sapiens:Interferon type I signaling pathways ‎(104 revisions)
22. Homo sapiens:Alzheimer's disease and miRNA effects ‎(101 revisions)
23. Homo sapiens:Amyotrophic lateral sclerosis (ALS) ‎(100 revisions)
24. Homo sapiens:Hematopoietic stem cell differentiation ‎(99 revisions)
25. Homo sapiens:One-carbon metabolism ‎(97 revisions)
26. Homo sapiens:Glycolysis and gluconeogenesis ‎(97 revisions)
27. Homo sapiens:Oxysterols derived from cholesterol ‎(94 revisions)
28. Homo sapiens:Fragile X syndrome ‎(94 revisions)
29. Homo sapiens:Purine metabolism and related disorders ‎(93 revisions)
30. Homo sapiens:T cell receptor and co-stimulatory signaling ‎(93 revisions)
31. Homo sapiens:Allograft rejection ‎(91 revisions)
32. Glycine max:Plant cell processes ‎(89 revisions)
33. Homo sapiens:Serotonin HTR1 group and FOS pathway ‎(88 revisions)
34. Saccharomyces cerevisiae:Nutrient control of ribosomal gene expression ‎(87 revisions)
35. Homo sapiens:Complement system ‎(86 revisions)
36. Homo sapiens:Tryptophan metabolism ‎(85 revisions)
37. Homo sapiens:Endothelin pathways ‎(83 revisions)
38. Homo sapiens:Statin inhibition of cholesterol production ‎(83 revisions)
39. Homo sapiens:miRNA regulation of DNA damage response ‎(82 revisions)
40. Homo sapiens:Heart development ‎(79 revisions)
41. Caenorhabditis elegans:ER stress-unfolded protein response (UPRer) ‎(78 revisions)
42. Homo sapiens:Neural crest differentiation ‎(78 revisions)
43. Homo sapiens:Iron metabolism disorders ‎(78 revisions)
44. Homo sapiens:Metabolic pathway of LDL, HDL and TG, including diseases ‎(77 revisions)
45. Mus musculus:Cholesterol metabolism with Bloch and Kandutsch-Russell pathways ‎(77 revisions)
46. Homo sapiens:Blakely Network ‎(76 revisions)
47. Homo sapiens:Vitamin A and carotenoid metabolism ‎(75 revisions)
48. Homo sapiens:Pyrimidine metabolism and related diseases ‎(73 revisions)
49. Homo sapiens:Energy metabolism ‎(71 revisions)
50. Rattus norvegicus:Renin-angiotensin system ‎(70 revisions)
51. Homo sapiens:Degradation pathway of sphingolipids, including diseases ‎(70 revisions)
52. Homo sapiens:Androgen receptor network in prostate cancer ‎(69 revisions)
53. Homo sapiens:Linoleic acid metabolism affected by SARS-CoV-2 ‎(69 revisions)
54. Homo sapiens:Glycerophospholipid biosynthetic pathway ‎(68 revisions)
55. Homo sapiens:Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism ‎(67 revisions)
56. Homo sapiens:Eicosanoid synthesis ‎(67 revisions)
57. Arabidopsis thaliana:Long-day flowering time pathway ‎(67 revisions)
58. Homo sapiens:Omega-6-fatty acids in senescence ‎(66 revisions)
59. Homo sapiens:Physiological and pathological hypertrophy of the heart ‎(65 revisions)
60. Homo sapiens:Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine ‎(64 revisions)
61. Homo sapiens:Disorders in ketone body synthesis ‎(64 revisions)
62. Homo sapiens:Disorders of bile acid synthesis and biliary transport ‎(64 revisions)
63. Homo sapiens:Pleural mesothelioma ‎(64 revisions)
64. Homo sapiens:Methionine metabolism leading to sulfur amino acids and related disorders ‎(63 revisions)
65. Homo sapiens:MicroRNAs in cardiomyocyte hypertrophy ‎(63 revisions)
66. Homo sapiens:Cell cycle ‎(63 revisions)
67. Homo sapiens:MAPK signaling pathway ‎(63 revisions)
68. Homo sapiens:TP53 network ‎(62 revisions)
69. Homo sapiens:Target of rapamycin signaling ‎(62 revisions)
70. Homo sapiens:Alanine and aspartate metabolism ‎(61 revisions)
71. Homo sapiens:Type II diabetes mellitus ‎(61 revisions)
72. Homo sapiens:Prostaglandin synthesis and regulation ‎(61 revisions)
73. Homo sapiens:Electron transport chain: OXPHOS system in mitochondria ‎(61 revisions)
74. Homo sapiens:Mitochondrial immune response to SARS-CoV-2 ‎(60 revisions)
75. Homo sapiens:miRNAs involved in DNA damage response ‎(60 revisions)
76. Homo sapiens:Sphingolipid pathway ‎(60 revisions)
77. Homo sapiens:Irinotecan pathway ‎(60 revisions)
78. Homo sapiens:Cholesterol synthesis disorders ‎(60 revisions)
79. Homo sapiens:Vitamin B6-dependent and responsive disorders ‎(60 revisions)
80. Homo sapiens:Liver steatosis adverse outcome pathway ‎(60 revisions)
81. Homo sapiens:Vitamin B12 disorders ‎(60 revisions)
82. Caenorhabditis elegans:Male mating ‎(59 revisions)
83. Homo sapiens:Estrogen signaling pathway ‎(59 revisions)
84. Homo sapiens:PDGF pathway ‎(59 revisions)
85. Homo sapiens:Wnt signaling pathway and pluripotency ‎(59 revisions)
86. Homo sapiens:Angiogenesis ‎(59 revisions)
87. Homo sapiens:Glycosylation and related congenital defects ‎(58 revisions)
88. Homo sapiens:Metabolic pathways of fibroblasts ‎(58 revisions)
89. Homo sapiens:Chronic hyperglycemia impairment of neuron function ‎(58 revisions)
90. Homo sapiens:Glioblastoma signaling pathways ‎(58 revisions)
91. Homo sapiens:Fluoropyrimidine activity ‎(58 revisions)
92. Mus musculus:Ptf1a related regulatory pathway ‎(58 revisions)
93. Homo sapiens:ACE inhibitor pathway ‎(58 revisions)
94. Homo sapiens:Angiogenesis overview ‎(58 revisions)
95. Homo sapiens:Neurotransmitter disorders ‎(58 revisions)
96. Arabidopsis thaliana:Flavonoid pathway ‎(57 revisions)
97. Homo sapiens:DNA damage response (only ATM dependent) ‎(57 revisions)
98. Homo sapiens:Selenium metabolism and selenoproteins ‎(57 revisions)
99. Homo sapiens:Spinal cord injury ‎(57 revisions)
100. Homo sapiens:Thyroxine (thyroid hormone) production ‎(56 revisions)
101. Homo sapiens:Tamoxifen metabolism ‎(56 revisions)
102. Homo sapiens:Iron metabolism in placenta ‎(55 revisions)
103. Homo sapiens:Myometrial relaxation and contraction pathways ‎(55 revisions)
104. Homo sapiens:GABA metabolism (aka GHB) ‎(54 revisions)
105. Homo sapiens:T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection ‎(54 revisions)
106. Homo sapiens:Fatty acid beta-oxidation ‎(54 revisions)
107. Homo sapiens:Ether lipid biosynthesis ‎(54 revisions)
108. Mus musculus:Amino acid metabolism ‎(54 revisions)
109. Homo sapiens:Apoptosis ‎(53 revisions)
110. Danio rerio:Fin development ‎(53 revisions)
111. Homo sapiens:Lung fibrosis ‎(53 revisions)
112. Homo sapiens:Aerobic glycolysis - augmented ‎(52 revisions)
113. Homo sapiens:22q11.2 copy number variation syndrome ‎(52 revisions)
114. Homo sapiens:Calcium regulation in cardiac cells ‎(52 revisions)
115. Homo sapiens:Wnt signaling pathway ‎(51 revisions)
116. Homo sapiens:AMP-activated protein kinase signaling ‎(51 revisions)
117. Mus musculus:Splicing factor NOVA regulated synaptic proteins ‎(51 revisions)
118. Saccharomyces cerevisiae:Tricarboxylic acid cycle ‎(51 revisions)
119. Homo sapiens:Endoplasmic reticulum stress response in coronavirus infection ‎(51 revisions)
120. Caenorhabditis elegans:Aging ‎(51 revisions)
121. Homo sapiens:Apoptosis modulation and signaling ‎(51 revisions)
122. Homo sapiens:Melatonin metabolism and effects ‎(50 revisions)
123. Homo sapiens:Cholesterol biosynthesis pathway ‎(50 revisions)
124. Homo sapiens:Blood clotting cascade ‎(50 revisions)
125. Homo sapiens:Hemesynthesis defects and porphyrias ‎(50 revisions)
126. Homo sapiens:Leucine, isoleucine and valine metabolism ‎(50 revisions)
127. Rattus norvegicus:p53 pathway ‎(50 revisions)
128. Homo sapiens:Prader-Willi and Angelman syndrome ‎(49 revisions)
129. Homo sapiens:Ciliopathies ‎(49 revisions)
130. Homo sapiens:SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction ‎(49 revisions)
131. Homo sapiens:VEGFA-VEGFR2 signaling ‎(49 revisions)
132. Homo sapiens:Type I interferon induction and signaling during SARS-CoV-2 infection ‎(49 revisions)
133. Mus musculus:Serotonin and anxiety ‎(49 revisions)
134. Danio rerio:FGF signaling pathway ‎(49 revisions)
135. Homo sapiens:Disorders of folate metabolism and transport ‎(49 revisions)
136. Homo sapiens:Wnt signaling ‎(48 revisions)
137. Homo sapiens:Acute viral myocarditis ‎(48 revisions)
138. Homo sapiens:Cerebral organic acidurias, including diseases ‎(48 revisions)
139. Homo sapiens:Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs) ‎(48 revisions)
140. Homo sapiens:Synaptic vesicle pathway ‎(47 revisions)
141. Gallus gallus:Chicken limb development ‎(47 revisions)
142. Homo sapiens:Fatty acid biosynthesis ‎(47 revisions)
143. Homo sapiens:Tyrosine metabolism and related disorders ‎(47 revisions)
144. Homo sapiens:Regulation of actin cytoskeleton ‎(47 revisions)
145. Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases ‎(47 revisions)
146. Rattus norvegicus:Relationship between glutathione and NADPH ‎(47 revisions)
147. Homo sapiens:Metapathway biotransformation Phase I and II ‎(47 revisions)
148. Homo sapiens:Parkinson's disease pathway ‎(46 revisions)
149. Homo sapiens:Cytokines and inflammatory response ‎(46 revisions)
150. Mus musculus:Distal convoluted tubule 1 (DCT1) cell ‎(46 revisions)
151. Homo sapiens:MECP2 and associated Rett syndrome ‎(46 revisions)
152. Escherichia coli:SK UDPglcnac ‎(46 revisions)
153. Homo sapiens:Focal adhesion ‎(45 revisions)
154. Homo sapiens:Complement activation ‎(45 revisions)
155. Homo sapiens:Estrogen metabolism ‎(45 revisions)
156. Rattus norvegicus:Fructose metabolism in proximal tubules ‎(45 revisions)
157. Homo sapiens:Glyoxylate metabolism ‎(45 revisions)
158. Homo sapiens:Extrafollicular and follicular B cell activation by SARS-CoV-2 ‎(45 revisions)
159. Mus musculus:ESC pluripotency pathways ‎(45 revisions)
160. Homo sapiens:Oxidation by cytochrome P450 ‎(45 revisions)
161. Saccharomyces cerevisiae:Filamentous growth pathway ‎(45 revisions)
162. Homo sapiens:Prion disease pathway ‎(45 revisions)
163. Homo sapiens:Triacylglyceride synthesis ‎(44 revisions)
164. Homo sapiens:Fas ligand pathway and stress induction of heat shock proteins ‎(44 revisions)
165. Homo sapiens:COVID-19, thrombosis and anticoagulation ‎(44 revisions)
166. Homo sapiens:Methionine de novo and salvage pathway ‎(44 revisions)
167. Homo sapiens:T-cell activation SARS-CoV-2 ‎(44 revisions)
168. Homo sapiens:Ferroptosis ‎(44 revisions)
169. Homo sapiens:Disorders of fructose metabolism ‎(44 revisions)
170. Homo sapiens:Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases ‎(44 revisions)
171. Homo sapiens:MTHFR deficiency ‎(44 revisions)
172. Homo sapiens:Pathogenic Escherichia coli infection ‎(44 revisions)
173. Homo sapiens:Histone modifications ‎(44 revisions)
174. Homo sapiens:Disorders of galactose metabolism ‎(43 revisions)
175. Rattus norvegicus:Proximal tubule transporters ‎(43 revisions)
176. Rattus norvegicus:Genetic alterations of lung cancer ‎(43 revisions)
177. Danio rerio:Canonical wnt signaling ‎(43 revisions)
178. Homo sapiens:Nanomaterial induced apoptosis ‎(43 revisions)
179. Homo sapiens:Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway ‎(43 revisions)
180. Homo sapiens:Microtubule cytoskeleton regulation ‎(42 revisions)
181. Mycobacterium tuberculosis:Citrate cycle (TCA cycle) ‎(42 revisions)
182. Homo sapiens:Riboflavin and CoQ disorders ‎(42 revisions)
183. Caenorhabditis elegans:Vulval development ‎(42 revisions)
184. Mus musculus:Limb development ‎(42 revisions)
185. Homo sapiens:Complement and coagulation cascades ‎(42 revisions)
186. Homo sapiens:TGF-beta signaling pathway ‎(42 revisions)
187. Homo sapiens:7q11.23 copy number variation syndrome ‎(42 revisions)
188. Rattus norvegicus:Hexoses metabolism in proximal tubules ‎(42 revisions)
189. Homo sapiens:Gastric acid production ‎(42 revisions)
190. Homo sapiens:Nicotine effect on dopaminergic neurons ‎(42 revisions)
191. Homo sapiens:DIV ‎(42 revisions)
192. Homo sapiens:G1 to S cell cycle control ‎(42 revisions)
193. Homo sapiens:Oxidative stress response ‎(42 revisions)
194. Homo sapiens:Metabolism of sphingolipids in ER and Golgi apparatus ‎(41 revisions)
195. Homo sapiens:Trans-sulfuration, one-carbon metabolism and related pathways ‎(41 revisions)
196. Homo sapiens:Insulin signaling ‎(41 revisions)
197. Homo sapiens:Biosynthesis and turnover of 1-deoxy-sphingoid bases ‎(41 revisions)
198. Homo sapiens:Creatine pathway ‎(40 revisions)
199. Homo sapiens:Monoamine GPCRs ‎(40 revisions)
200. Homo sapiens:Nuclear receptors meta-pathway ‎(40 revisions)
201. Homo sapiens:GPCRs, class A rhodopsin-like ‎(40 revisions)
202. Homo sapiens:Immune infiltration in pancreatic cancer ‎(40 revisions)
203. Zea mays:Vitamin B1 (thiamin) biosynthesis and salvage pathway ‎(40 revisions)
204. Homo sapiens:Integrated cancer pathway ‎(40 revisions)
205. Mus musculus:One-carbon metabolism ‎(40 revisions)
206. Homo sapiens:Toll-like receptor signaling pathway ‎(40 revisions)
207. Homo sapiens:Inflammatory bowel disease signaling ‎(40 revisions)
208. Homo sapiens:Estradiol regulation in porto-sinusoidal vascular disease ‎(39 revisions)
209. Homo sapiens:Osteoblast signaling ‎(39 revisions)
210. Homo sapiens:Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia ‎(39 revisions)
211. Homo sapiens:Bladder cancer ‎(39 revisions)
212. Homo sapiens:IL-1 signaling pathway ‎(39 revisions)
213. Homo sapiens:Chromosomal and microsatellite instability in colorectal cancer ‎(39 revisions)
214. Rattus norvegicus:Alanine and aspartate metabolism ‎(39 revisions)
215. Homo sapiens:Ovarian infertility ‎(39 revisions)
216. Homo sapiens:Polycystic kidney disease pathway ‎(39 revisions)
217. Mus musculus:Elongation of (very) long chain fatty acids ‎(38 revisions)
218. Homo sapiens:Cori cycle ‎(38 revisions)
219. Mus musculus:Eicosanoid metabolism via cyclooxygenases (COX) ‎(38 revisions)
220. Mycobacterium tuberculosis:Biotin metabolism ‎(38 revisions)
221. Homo sapiens:Vitamin K metabolism and activation of dependent proteins ‎(38 revisions)
222. Homo sapiens:Transcriptional activation by NRF2 in response to phytochemicals ‎(38 revisions)
223. Homo sapiens:Krebs cycle disorders ‎(38 revisions)
224. Saccharomyces cerevisiae:Pentose phosphate pathway 2 ‎(38 revisions)
225. Homo sapiens:Mevalonate arm of cholesterol biosynthesis pathway ‎(38 revisions)
226. Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4 ‎(38 revisions)
227. Rattus norvegicus:Glycolysis and gluconeogenesis ‎(38 revisions)
228. Homo sapiens:Overlap between signal transduction pathways contributing to LMNA laminopathies ‎(38 revisions)
229. Homo sapiens:Osteoclast signaling ‎(38 revisions)
230. Homo sapiens:TNF-alpha signaling pathway ‎(37 revisions)
231. Homo sapiens:PtdIns(4,5)P2 in cytokinesis pathway ‎(37 revisions)
232. Homo sapiens:Urea cycle and associated pathways ‎(37 revisions)
233. Homo sapiens:Thyroid stimulating hormone (TSH) signaling pathway ‎(37 revisions)
234. Homo sapiens:Spina bifida ‎(37 revisions)
235. Homo sapiens:Peptide GPCRs ‎(37 revisions)
236. Rattus norvegicus:Fatty acid beta-oxidation ‎(37 revisions)
237. Homo sapiens:Prostaglandin and leukotriene metabolism in senescence ‎(37 revisions)
238. Homo sapiens:TGF-beta receptor signaling ‎(37 revisions)
239. Homo sapiens:DNA replication ‎(37 revisions)
240. Homo sapiens:Female steroid hormones in cardiomyocyte energy metabolism ‎(37 revisions)
241. Homo sapiens:mRNA processing ‎(37 revisions)
242. Homo sapiens:Urea cycle and related diseases ‎(37 revisions)
243. Homo sapiens:Nod-like receptor (NLR) signaling pathway ‎(37 revisions)
244. Homo sapiens:Gastric cancer network 1 ‎(37 revisions)
245. Homo sapiens:Acetylcholine synthesis ‎(37 revisions)
246. Homo sapiens:Osteoarthritic chondrocyte hypertrophy ‎(37 revisions)
247. Homo sapiens:Endometrial cancer ‎(37 revisions)
248. Homo sapiens:Codeine and morphine metabolism ‎(36 revisions)
249. Homo sapiens:Cysteine and methionine catabolism ‎(36 revisions)
250. Homo sapiens:Nuclear receptors in lipid metabolism and toxicity ‎(36 revisions)
251. Homo sapiens:Biogenic amine synthesis ‎(36 revisions)
252. Homo sapiens:Alternative pathway of fetal androgen synthesis ‎(36 revisions)
253. Homo sapiens:Growth factors and hormones in beta cell proliferation ‎(36 revisions)
254. Homo sapiens:Proteasome degradation ‎(36 revisions)
255. Homo sapiens:Leukotriene metabolic pathway ‎(36 revisions)
256. Homo sapiens:Arylamine metabolism ‎(36 revisions)
257. Homo sapiens:MAPK cascade ‎(36 revisions)
258. Homo sapiens:Physico-chemical features and toxicity-associated pathways ‎(36 revisions)
259. Homo sapiens:Downregulation of ACE2 by SARS-CoV-2 spike protein ‎(36 revisions)
260. Homo sapiens:DYRK1A involvement regarding cell proliferation in brain development ‎(36 revisions)
261. Homo sapiens:Oxidative phosphorylation ‎(35 revisions)
262. Rattus norvegicus:p53 signal pathway ‎(35 revisions)
263. Mus musculus:Folic acid network ‎(35 revisions)
264. Homo sapiens:IL6 signaling pathway ‎(35 revisions)
265. Rattus norvegicus:Cholesterol metabolism ‎(35 revisions)
266. Homo sapiens:TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) ‎(35 revisions)
267. Homo sapiens:Hijack of ubiquitination by SARS-CoV-2 ‎(35 revisions)
268. Arabidopsis thaliana:Flowering time pathway ‎(35 revisions)
269. Homo sapiens:Nicotine metabolism in liver cells ‎(35 revisions)
270. Homo sapiens:Biotin metabolism, including IMDs ‎(35 revisions)
271. Homo sapiens:Sulfatase and aromatase pathway ‎(35 revisions)
272. Mus musculus:Glycolysis and gluconeogenesis ‎(35 revisions)
273. Homo sapiens:Measles virus infection ‎(35 revisions)
274. Homo sapiens:Heme biosynthesis ‎(35 revisions)
275. Mus musculus:Regulation of cardiac hypertrophy by miR-208 ‎(35 revisions)
276. Homo sapiens:DNA mismatch repair ‎(35 revisions)
277. Gibberella zeae:DON mycotoxin biosynthesis ‎(35 revisions)
278. Homo sapiens:Serotonin receptor 4/6/7 and NR3C signaling ‎(35 revisions)
279. Homo sapiens:7-oxo-C and 7-beta-HC pathways ‎(34 revisions)
280. Rattus norvegicus:Catecholamine synthesis ‎(34 revisions)
281. Homo sapiens:Primary focal segmental glomerulosclerosis (FSGS) ‎(34 revisions)
282. Homo sapiens:G protein signaling pathways ‎(34 revisions)
283. Homo sapiens:Non-homologous end joining ‎(34 revisions)
284. Mus musculus:Statin pathway ‎(34 revisions)
285. Mus musculus:GPCRs, other ‎(34 revisions)
286. Homo sapiens:Head and neck squamous cell carcinoma ‎(34 revisions)
287. Homo sapiens:Steroid biosynthesis ‎(34 revisions)
288. Homo sapiens:Glycogen synthesis and degradation ‎(34 revisions)
289. Homo sapiens:SARS-CoV-2 innate immunity evasion and cell-specific immune response ‎(34 revisions)
290. Homo sapiens:T cell modulation in pancreatic cancer ‎(34 revisions)
291. Homo sapiens:Aflatoxin B1 metabolism ‎(34 revisions)
292. Homo sapiens:IL-4 signaling pathway ‎(34 revisions)
293. Homo sapiens:Sulfation biotransformation reaction ‎(34 revisions)
294. Mus musculus:Calcium regulation in cardiac cells ‎(34 revisions)
295. Homo sapiens:Regulation of toll-like receptor signaling pathway ‎(34 revisions)
296. Homo sapiens:IL-2 signaling pathway ‎(34 revisions)
297. Homo sapiens:Eukaryotic transcription initiation ‎(34 revisions)
298. Homo sapiens:Pentose phosphate metabolism ‎(34 revisions)
299. Homo sapiens:IL-7 signaling pathway ‎(34 revisions)
300. Homo sapiens:Notch signaling ‎(34 revisions)
301. Homo sapiens:Angiotensin II receptor type 1 pathway ‎(33 revisions)
302. Homo sapiens:Roles of ceramides in development of insulin resistance ‎(33 revisions)
303. Rattus norvegicus:VEGF-receptor signal transduction ‎(33 revisions)
304. Homo sapiens:Apoptosis modulation by HSP70 ‎(33 revisions)
305. Saccharomyces cerevisiae:Phosphatidic acid and phospholipid biosynthesis ‎(33 revisions)
306. Mus musculus:Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling ‎(33 revisions)
307. Plasmodium falciparum:Isoprenoid precursor biosynthesis in Pf apicoplasts ‎(33 revisions)
308. Homo sapiens:Cardiac progenitor differentiation ‎(33 revisions)
309. Homo sapiens:Nanoparticle triggered regulated necrosis ‎(33 revisions)
310. Caenorhabditis elegans:Metapathway signal transduction ‎(33 revisions)
311. Homo sapiens:Affected pathways in Duchenne muscular dystrophy ‎(33 revisions)
312. Mycobacterium tuberculosis:D-arginine and D-ornithine metabolism ‎(33 revisions)
313. Homo sapiens:Androgen receptor signaling pathway ‎(33 revisions)
314. Mus musculus:Glutathione and one-carbon metabolism ‎(33 revisions)
315. Homo sapiens:Serine metabolism ‎(33 revisions)
316. Homo sapiens:EGF/EGFR signaling pathway ‎(33 revisions)
317. Homo sapiens:RAS and bradykinin pathways in COVID-19 ‎(32 revisions)
318. Mus musculus:Focal adhesion ‎(32 revisions)
319. Saccharomyces cerevisiae:High-osmolarity glycerol (HOG) pathway ‎(32 revisions)
320. Saccharomyces cerevisiae:Glycolysis and gluconeogenesis ‎(32 revisions)
321. Homo sapiens:Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution ‎(32 revisions)
322. Homo sapiens:Breast cancer pathway ‎(32 revisions)
323. Zea mays:Vitamin B3 (niacin), NAD and NADP biosynthesis pathway ‎(32 revisions)
324. Homo sapiens:Glucuronidation ‎(32 revisions)
325. Homo sapiens:Glutathione metabolism ‎(32 revisions)
326. Homo sapiens:Aerobic glycolysis ‎(32 revisions)
327. Homo sapiens:Hypothesized pathways in pathogenesis of cardiovascular disease ‎(32 revisions)
328. Homo sapiens:Angiopoietin-like protein 8 regulatory pathway ‎(32 revisions)
329. Homo sapiens:B cell receptor signaling pathway ‎(32 revisions)
330. Drosophila melanogaster:Fatty acid biosynthesis ‎(32 revisions)
331. Mus musculus:Microglia pathogen phagocytosis pathway ‎(32 revisions)
332. Homo sapiens:Cell-type dependent selectivity of CCK2R signaling ‎(32 revisions)
333. Homo sapiens:AXL signaling pathway ‎(32 revisions)
334. Homo sapiens:Ebola virus infection in host ‎(32 revisions)
335. Arabidopsis thaliana:Plant primary metabolism ‎(32 revisions)
336. Homo sapiens:Mitochondrial long chain fatty acid beta-oxidation ‎(32 revisions)
337. Homo sapiens:Host-pathogen interaction of human coronaviruses - MAPK signaling ‎(32 revisions)
338. Rattus norvegicus:ATM signaling pathway ‎(32 revisions)
339. Homo sapiens:Oligodendrocyte specification and differentiation, leading to myelin components for CNS ‎(31 revisions)
340. Homo sapiens:Corticotropin-releasing hormone signaling pathway ‎(31 revisions)
341. Homo sapiens:Gastric cancer network 2 ‎(31 revisions)
342. Homo sapiens:Cell cycle checkpoints ‎(31 revisions)
343. Mus musculus:Electron transport chain ‎(31 revisions)
344. Homo sapiens:Rett syndrome ‎(31 revisions)
345. Gallus gallus:Toll-like receptor pathway ‎(31 revisions)
346. Homo sapiens:Endochondral ossification ‎(31 revisions)
347. Homo sapiens:3q29 copy number variation syndrome ‎(31 revisions)
348. Homo sapiens:Inflammatory response pathway ‎(31 revisions)
349. Anopheles gambiae:GPCR-Calcium ‎(31 revisions)
350. Homo sapiens:Endochondral ossification with skeletal dysplasias ‎(31 revisions)
351. Mus musculus:GPCRs, class A rhodopsin-like ‎(31 revisions)
352. Caenorhabditis elegans:Crystal toxin triggered necrosis pathway ‎(31 revisions)
353. Homo sapiens:Formation of Fibrin Clot and the Clotting Cascade ‎(31 revisions)
354. Mus musculus:Selenium micronutrient network ‎(31 revisions)
355. Homo sapiens:MET in type 1 papillary renal cell carcinoma ‎(31 revisions)
356. Homo sapiens:G13 signaling pathway ‎(31 revisions)
357. Homo sapiens:Prostaglandin signaling ‎(30 revisions)
358. Rattus norvegicus:Pentose phosphate pathway ‎(30 revisions)
359. Mus musculus:Glucocorticoid and mineralcorticoid metabolism ‎(30 revisions)
360. Anopheles gambiae:testing testing ‎(30 revisions)
361. Homo sapiens:Small ligand GPCRs ‎(30 revisions)
362. Homo sapiens:Glial cell differentiation ‎(30 revisions)
363. Zea mays:Vitamin B5 (pantothenate) and CoA biosynthesis Pathway ‎(30 revisions)
364. Homo sapiens:Urea cycle and metabolism of amino groups ‎(30 revisions)
365. Homo sapiens:Notch signaling pathway ‎(30 revisions)
366. Homo sapiens:Thiamine metabolic pathways ‎(30 revisions)
367. Saccharomyces cerevisiae:Crabtree effect ‎(30 revisions)
368. Mus musculus:Tryptophan metabolism ‎(30 revisions)
369. Homo sapiens:Dravet syndrome ‎(30 revisions)
370. Oryza sativa:Seed development ‎(30 revisions)
371. Homo sapiens:EGFR tyrosine kinase inhibitor resistance ‎(30 revisions)
372. Homo sapiens:NRP1-triggered signaling pathways in pancreatic cancer ‎(30 revisions)
373. Mus musculus:Tyrobp causal network in microglia ‎(30 revisions)
374. Mus musculus:Serotonin and anxiety-related events ‎(30 revisions)
375. Homo sapiens:Flavan-3-ol metabolic pathway ‎(30 revisions)
376. Drosophila melanogaster:Toll, IMD, JAK/STAT pathways for immune response to pathogens ‎(30 revisions)
377. Homo sapiens:Alpha 6 beta 4 signaling pathway ‎(30 revisions)
378. Saccharomyces cerevisiae:TCA cycle ‎(30 revisions)
379. Homo sapiens:Familial partial lipodystrophy ‎(29 revisions)
380. Homo sapiens:GPCRs, other ‎(29 revisions)
381. Homo sapiens:Hedgehog signaling pathway ‎(29 revisions)
382. Homo sapiens:SARS-CoV-2 and ACE2 receptor: molecular mechanisms ‎(29 revisions)
383. Homo sapiens:Phase I biotransformations, non-P450 ‎(29 revisions)
384. Rattus norvegicus:Thick ascending limb transporters ‎(29 revisions)
385. Rattus norvegicus:Electron transport chain ‎(29 revisions)
386. Homo sapiens:Dopamine metabolism ‎(29 revisions)
387. Homo sapiens:Pilocytic astrocytoma ‎(29 revisions)
388. Homo sapiens:FGFR3 signaling in chondrocyte proliferation and terminal differentiation ‎(29 revisions)
389. Homo sapiens:CAMKK2 pathway ‎(29 revisions)
390. Homo sapiens:Molybdenum cofactor (Moco) biosynthesis ‎(29 revisions)
391. Oryza sativa:Octadecanoid pathway ‎(29 revisions)
392. Rattus norvegicus:Angiotensin II signaling (acute) in thick ascending limbs ‎(29 revisions)
393. Saccharomyces cerevisiae:MAPK signaling pathway ‎(29 revisions)
394. Mus musculus:Mecp2 and associated Rett syndrome ‎(29 revisions)
395. Danio rerio:Nodal signaling pathway ‎(29 revisions)
396. Homo sapiens:Proline and hydroxyproline pathways ‎(29 revisions)
397. Homo sapiens:Hepatocyte growth factor receptor signaling ‎(29 revisions)
398. Homo sapiens:Mineralocorticoid biosynthesis ‎(29 revisions)
399. Homo sapiens:Major receptors targeted by epinephrine and norepinephrine ‎(29 revisions)
400. Homo sapiens:Cholesterol biosynthesis ‎(29 revisions)
401. Saccharomyces cerevisiae:Glucose repression ‎(29 revisions)
402. Zea mays:Vitamin B9 (folate) biosynthesis pathway ‎(29 revisions)
403. Homo sapiens:16p11.2 proximal deletion syndrome ‎(29 revisions)
404. Homo sapiens:PI3K/AKT/mTOR - vitamin D3 signaling ‎(29 revisions)
405. Mus musculus:Myometrial relaxation and contraction pathways ‎(29 revisions)
406. Rattus norvegicus:Wnt myofibroblastic activation of hepatic stellate cells ‎(28 revisions)
407. Saccharomyces cerevisiae:Glucose-1-phosphate metabolism ‎(28 revisions)
408. Rattus norvegicus:Folic acid network ‎(28 revisions)
409. Homo sapiens:NAD metabolism, sirtuins and aging ‎(28 revisions)
410. Mus musculus:Primary focal segmental glomerulosclerosis (FSGS) ‎(28 revisions)
411. Homo sapiens:Calcium mediated T-cell apoptosis involved in inclusion body myositis ‎(28 revisions)
412. Caenorhabditis elegans:TCA cycle ‎(28 revisions)
413. Escherichia coli:Escherichia coli K-12 peripherome ‎(28 revisions)
414. Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway ‎(28 revisions)
415. Homo sapiens:TCA cycle nutrient use and invasiveness of ovarian cancer ‎(28 revisions)
416. Mus musculus:Dopaminergic neurogenesis ‎(28 revisions)
417. Homo sapiens:Cell interactions of the pancreatic cancer microenvironment ‎(28 revisions)
418. Homo sapiens:Clear cell renal cell carcinoma pathways ‎(28 revisions)
419. Caenorhabditis elegans:Cell engulfment ‎(28 revisions)
420. Rattus norvegicus:NFE2L2 ‎(28 revisions)
421. Homo sapiens:Vitamin D receptor pathway ‎(28 revisions)
422. Arabidopsis thaliana:2-acetyl-1-pyrroline pathway ‎(28 revisions)
423. Homo sapiens:p38 MAPK signaling pathway ‎(28 revisions)
424. Homo sapiens:IL-9 signaling pathway ‎(28 revisions)
425. Homo sapiens:Parkin-ubiquitin proteasomal system pathway ‎(28 revisions)
426. Homo sapiens:IL-5 signaling pathway ‎(28 revisions)
427. Homo sapiens:Hair follicle development: induction - stage 1 of 3 ‎(28 revisions)
428. Homo sapiens:Thyroid hormones production and peripheral downstream signaling effects ‎(28 revisions)
429. Homo sapiens:Transport of glycerol from adipocytes to liver by aquaporins ‎(28 revisions)
430. Mus musculus:Wnt signaling in kidney disease ‎(28 revisions)
431. Homo sapiens:Non-small cell lung cancer ‎(28 revisions)
432. Homo sapiens:Response to elevated platelet cytosolic Ca ions ‎(28 revisions)
433. Mus musculus:Deregulation of renin-angiotensin system by SARS-CoV infection ‎(28 revisions)
434. Homo sapiens:Pyrimidine metabolism ‎(28 revisions)
435. Homo sapiens:Serotonin receptor 2 and ELK-SRF/GATA4 signaling ‎(28 revisions)
436. Homo sapiens:Amino acid conjugation of benzoic acid ‎(28 revisions)
437. Homo sapiens:Aryl hydrocarbon receptor pathway ‎(28 revisions)
438. Homo sapiens:S1P receptor signal transduction ‎(28 revisions)
439. Homo sapiens:IL-17 signaling pathway ‎(28 revisions)
440. Homo sapiens:Nucleotide metabolism ‎(28 revisions)
441. Homo sapiens:4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression ‎(28 revisions)
442. Homo sapiens:Benzo(a)pyrene metabolism ‎(27 revisions)
443. Homo sapiens:Amino acid transport defects (IEMs) ‎(27 revisions)
444. Mycobacterium tuberculosis:Lipoic acid metabolism ‎(27 revisions)
445. Homo sapiens:Ulcerative colitis signaling ‎(27 revisions)
446. Homo sapiens:Carnosine metabolism of glial cells ‎(27 revisions)
447. Homo sapiens:Mitochondrial beta-oxidation ‎(27 revisions)
448. Homo sapiens:Integrin-mediated cell adhesion ‎(27 revisions)
449. Mus musculus:Mapk signaling pathway ‎(27 revisions)
450. Homo sapiens:Lactate shuttle in glial cells ‎(27 revisions)
451. Homo sapiens:Polyol pathway ‎(27 revisions)
452. Bos taurus:Folate metabolism ‎(27 revisions)
453. Homo sapiens:Sphingolipid metabolism in senescence ‎(27 revisions)
454. Danio rerio:TCA cycle ‎(27 revisions)
455. Homo sapiens:Ganglio sphingolipid metabolism ‎(27 revisions)
456. Homo sapiens:Eukaryotic translation initiation ‎(27 revisions)
457. Homo sapiens:Post-translational modification: synthesis of GPI-anchored proteins ‎(27 revisions)
458. Homo sapiens:PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer ‎(27 revisions)
459. Homo sapiens:Alstrom syndrome ‎(27 revisions)
460. Arabidopsis thaliana:Kaempferol derivatives ‎(27 revisions)
461. Mus musculus:Purine metabolism ‎(27 revisions)
462. Mus musculus:Focal adhesion: PI3K-Akt-mTOR signaling pathway ‎(27 revisions)
463. Homo sapiens:Opioid signaling ‎(27 revisions)
464. Homo sapiens:SRF and miRs in smooth muscle differentiation and proliferation ‎(27 revisions)
465. Homo sapiens:Cannabinoid receptor signaling ‎(27 revisions)
466. Homo sapiens:RANKL/RANK signaling pathway ‎(27 revisions)
467. Mus musculus:Chemokine signaling pathway ‎(27 revisions)
468. Homo sapiens:Common pathways underlying drug addiction ‎(27 revisions)
469. Homo sapiens:Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins ‎(27 revisions)
470. Rattus norvegicus:Glucocorticoid effect on target gene expression ‎(27 revisions)
471. Homo sapiens:Folate-alcohol and cancer pathway hypotheses ‎(27 revisions)
472. Homo sapiens:Focal adhesion: PI3K-Akt-mTOR-signaling pathway ‎(27 revisions)
473. Homo sapiens:Epigallocatechin-3-O-gallate / epigallocatechin / epicatechin breakdown pathway ‎(26 revisions)
474. Homo sapiens:Apoptotic execution phase ‎(26 revisions)
475. Homo sapiens:Pluripotent stem cell differentiation pathway ‎(26 revisions)
476. Homo sapiens:MicroRNAs in cardiomyocyte hypertrophy 2 ‎(26 revisions)
477. Rattus norvegicus:Triacylglyceride synthesis ‎(26 revisions)
478. Homo sapiens:Activation of gene expression by SREBF (SREBP) ‎(26 revisions)
479. Rattus norvegicus:Irinotecan pathway ‎(26 revisions)
480. Homo sapiens:Regulation of apoptosis by parathyroid hormone-related protein ‎(26 revisions)
481. Mus musculus:FAS pathway and stress induction of HSP regulation ‎(26 revisions)
482. Mus musculus:Mapk cascade ‎(26 revisions)
483. Homo sapiens:Rap1 signaling ‎(26 revisions)
484. Mus musculus:Adar1 editing defficiency immune response ‎(26 revisions)
485. Homo sapiens:Ras signaling ‎(26 revisions)
486. Homo sapiens:Fatty acid omega-oxidation ‎(26 revisions)
487. Homo sapiens:Copper homeostasis ‎(26 revisions)
488. Homo sapiens:Signaling by VEGF ‎(26 revisions)
489. Homo sapiens:Metabolic epileptic disorders ‎(26 revisions)
490. Homo sapiens:Exercise-induced circadian regulation ‎(26 revisions)
491. Homo sapiens:Pathways affected in adenoid cystic carcinoma ‎(26 revisions)
492. Homo sapiens:IL-3 signaling pathway ‎(26 revisions)
493. Homo sapiens:Interleukin-1 family signaling ‎(26 revisions)
494. Homo sapiens:Influence of laminopathies on Wnt signaling ‎(26 revisions)

View (previous 500) (next 500) (20 | 50 | 100 | 250 | 500)